Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Research of Therapeutic Target Enzymes (Deadline: 27 September 2024)
- Hormone/Receptor System in Human Diseases (Deadline: 30 September 2024)
- Revealing New Molecular Mechanisms in Medicinal Chemistry (Deadline: 30 September 2024)
- Role of Natural Products in Health and Diseases (Deadline: 30 September 2024)
- Selected Papers for the 30th International Conference on Chelation (ICOC)—a Landmark on Metal Chelation Science and Medicine (Deadline: 30 September 2024)
- Molecular Pharmacology of Cardiovascular Disease, 2nd Edition (Deadline: 30 September 2024)
- Latest Review Papers in Molecular Pharmacology 2024 (Deadline: 30 September 2024)
- Molecular Research on Antibody–Drug Conjugates (Deadline: 30 September 2024)
- Nutrients, Natural Products and Nanoparticles for the Development of New Therapeutic Agents (Deadline: 30 September 2024)
- New Drugs Regulating Cytoskeletons in Human Health and Diseases (Deadline: 30 September 2024)
- Application of Natural Products in Biomedicine and Pharmacotherapy: 2nd Edition (Deadline: 30 September 2024)
- Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies, 3rd Edition (Deadline: 15 October 2024)
- Current Research in Pharmacognosy: A Focus on Biological Activities (Deadline: 20 October 2024)
- Natural Bioactive Compounds for Human Health, 2nd Edition (Deadline: 20 October 2024)
- Molecular Mechanisms and Therapeutic Approaches to Osteoarthritis (Deadline: 20 October 2024)
- Antiviral Activity of Lectins (Deadline: 20 October 2024)
- Advances in Anti-inflammatory Drug Development (Deadline: 20 October 2024)
- Medical Value of Metal Complexes and Plant-Derived Compounds: Biological Evaluation, Health Effects, Challenges, and Future Opportunities (Deadline: 25 October 2024)
- Anticancer Antibiotics: Progresses, Opportunities and Challenges (Deadline: 30 October 2024)
- Pharmacological Treatment of Neuropsychiatric Disorders (Deadline: 30 October 2024)
- Molecular Advances on Cannabinoid and Endocannabinoid Research 2.0 (Deadline: 31 October 2024)
- Structure–Activity Relationships within Pharmaceutical Interactions and the Discovery of Molecular Targets (Deadline: 31 October 2024)
- Molecular Mechanisms of Herbal Compounds in Neuroprotection (Deadline: 10 November 2024)
- New Agents and Novel Drugs Use for the Oncological Diseases Treatment (Deadline: 15 November 2024)
- Recent Approaches for Wound Treatment—2nd Edition (Deadline: 20 November 2024)
- Recent Progress of Opioid Research, 2nd Edition (Deadline: 20 November 2024)
- Metal-Based Drugs and Research on Mechanisms of Action (Deadline: 20 November 2024)
- Advanced Research on Chemokines and Chemokine Receptors (Deadline: 20 November 2024)
- Drug Treatment for Bacterial Infections (Deadline: 20 November 2024)
- Molecular Pharmacology of Antidepressants (Deadline: 20 November 2024)
- Synthesis and Molecular Research of Drugs for Skin Diseases and Cosmetic Ingredients (Deadline: 30 November 2024)
- Synthetic and Natural Drugs for Pain Treatment (Deadline: 30 November 2024)
- Antituberculous Drugs: Progress and Challenges (Deadline: 30 November 2024)
- The Role of Bioactive Compounds in Human Health and Disease: 2nd Edition (Deadline: 30 November 2024)
- Drug Repurposing in Rare Diseases: From Molecular Insights to Patient Benefits (Deadline: 30 November 2024)
- Molecular Pharmacology and Metabolic Signaling in Health and Disease (Deadline: 30 November 2024)
- Biomedical Applications of Mesenchymal Stem Cells (Deadline: 30 November 2024)
- Drug Resistance and Biomarkers in Molecular Oncology (Deadline: 30 November 2024)
- Discovering Novel Bioactive Compounds against Cancers (Deadline: 30 November 2024)
- Bioactive Peptides: Synthesis, Functions, and Medicinal Chemistry Applications (Deadline: 30 November 2024)
- Phytochemicals for Diabetes: Natural Plant-Based Therapies (Deadline: 30 November 2024)
- Molecular Pharmacology of Medicinal Plants (Deadline: 30 November 2024)
- Proteomics and Nanotechnology for Medical and Pharmacological Applications (Deadline: 30 November 2024)
- Synthesis and Application of Chiral Ligands and Heterocycles in Pharmacological Studies (Deadline: 30 November 2024)
- Endocannabinoid Receptors in Human Health and Disease, 2nd Edition (Deadline: 10 December 2024)
- Advances in Drug Delivery Systems: From Nanoparticles to Precision Medicine (Deadline: 15 December 2024)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition (Deadline: 15 December 2024)
- Anti-cancer Effects of Natural Products (Deadline: 20 December 2024)
- Advanced Research on N-chlorotaurine and Other Active Halogen Taurine Derivatives (Deadline: 20 December 2024)
- Zinc Enzymes for Drug Design and Drug Development (Deadline: 20 December 2024)
- Drug Resistance in Cancer: Molecular Mechanisms and Tackling Strategies, 2nd Edition (Deadline: 20 December 2024)
- Small Interfering RNAs, CRISPR, Antisense Drugs, and Therapeutic Oligonucleotide Analogues for Diagnostic Profiling, Genome Editing, and for Manipulation of Gene Expression (Deadline: 20 December 2024)
- Advanced Research on the Adrenal Gland and Hormones (Deadline: 20 December 2024)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities (Deadline: 20 December 2024)
- Drug Design and Development for Neurological Diseases (Deadline: 20 December 2024)
- Carbohydrate Structures in Targeted Drug Delivery (Deadline: 20 December 2024)
- Flow Cytometry for Safety Assessment in Drug Discovery (Deadline: 20 December 2024)
- Gene-Level Pharmacological Research on Natural Products (Deadline: 20 December 2024)
- Medicinal Chemistry: From Drug Design to Drug Development (Deadline: 20 December 2024)
- Cutting-Edge Research on Antiviral Therapy (Deadline: 20 December 2024)
- Biorhythm-Based Drug Design and Development (Deadline: 20 December 2024)
- Plant-Derived Natural Substances as Multi-target Therapeutic Modalities in Experimental Models of Non-communicable Diseases (Deadline: 20 December 2024)
- Biocatalysis of Compounds for Pharmaceutical and Biomedical Applications (Deadline: 30 December 2024)
- Advanced Synthetic Methodologies in Drug Development (Deadline: 30 December 2024)
- Research on Drug Metabolism and Disposition (Deadline: 31 December 2024)
- Natural Products: Potential New Anti-inflammatory Drugs (Deadline: 31 December 2024)
- Advances in Epilepsy and Antiepileptic Drugs, 3rd Edition (Deadline: 31 December 2024)
- Antiviral Drug Design, Synthesis and Molecular Mechanisms (Deadline: 31 December 2024)
- Antiviral Drugs Discovery (Deadline: 31 December 2024)
- Anticancer Drug Discovery Based on Natural Products (Deadline: 31 December 2024)
- Drug Therapy of Systemic Lupus Erythematosus (Deadline: 31 December 2024)
- New Advance in Radiopharmaceuticals and Radiotherapy (Deadline: 31 December 2024)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity, 3rd Edition (Deadline: 31 December 2024)
- Mechanistic and Small Molecule Discoveries for Therapeutic Advances in Hypertrophic and Dilated Cardiomyopathies (Deadline: 15 January 2025)
- Molecular Pharmacology in Diabetes, 2nd Edition (Deadline: 20 January 2025)
- Natural Compounds in Cancer Therapy and Prevention, 2nd Edition (Deadline: 20 January 2025)
- Drug Discovery and Development for Renal Disease Treatment (Deadline: 20 January 2025)
- Advances in Novel Anti-Alzheimer Drugs: Biological Target, Medicinal Chemistry and Formulation (Deadline: 20 January 2025)
- Computational Medicine and Molecular Drug Design (Deadline: 20 January 2025)
- Drug Delivery Systems: Current Status in the Treatment of Human Diseases (Deadline: 20 January 2025)
- Epilepsy Research and Antiepileptic Drugs, 2nd Edition (Deadline: 20 January 2025)
- Editorial Board Members’ Collection Series: Pain (Deadline: 20 January 2025)
- New Insights into Anti-cancer Drug Discovery and Development (Deadline: 20 January 2025)
- Thioredoxin Reductase: Signaling Pathways and Pharmacological Targets (Deadline: 20 January 2025)
- Mass Spectrometry Imaging for Drug Pharmacokinetics and Drug Delivery System (Deadline: 20 January 2025)
- Natural Products: Antioxidants and Neuroprotection (Deadline: 20 January 2025)
- Drug Discovery Based on Natural Products (Deadline: 20 January 2025)
- Molecular Insights into Drug Safety: Bridging Efficacy and Toxicity (Deadline: 20 January 2025)
- Molecular Advances in Liposome-Based Drug Delivery Systems (Deadline: 30 January 2025)
- Natural Compounds and Strategies for Developing Novel Anti-Inflammatory Drugs (Deadline: 30 January 2025)
- Pharmacological Activities of Secondary Metabolites and Derivates of Medicinal Plants Around the World, 2nd Edition (Deadline: 30 January 2025)
- Lipid Emulsion and Other Treatment in Drug Toxicity (Deadline: 31 January 2025)
- G Protein-Coupled Receptor Drug Discovery: Recent Advances and Future Perspectives (Deadline: 31 January 2025)
- Medicinal Plants and Natural Compounds in Health and Disease: Progresses, Challenges, Opportunities, 2nd Edition (Deadline: 31 January 2025)
- Advancements in Diagnostic and Preventive Pharmacogenomics (Deadline: 31 January 2025)
- Drug Discovery: Design, Synthesis and Activity Evaluation (Deadline: 31 January 2025)
- Advances in Drug Discovery and Synthesis: 2nd Edition (Deadline: 31 January 2025)
- Molecular Pharmacology of Human Metabolism Diseases (Deadline: 20 February 2025)
- Aptamer-Based Tissue-Targeted Drug Delivery (Deadline: 20 February 2025)
- Recent Advances: Heterocycles in Drugs and Drug Discovery 2.0 (Deadline: 20 February 2025)
- Drugs in Inflammatory Bowel Diseases (Deadline: 20 February 2025)
- The Impact of Natural Bioactive Compounds on Human Health and Disease (Deadline: 20 February 2025)
- Nutrients and Natural Agents as Drug Leads for Product Development (Deadline: 20 February 2025)
- Insights into Redox Homeostasis and Oxidative Stress (Deadline: 20 February 2025)
- Novel Antimicrobial Agents (Deadline: 20 February 2025)
- Small Molecule Drug Design and Research: 3rd Edition (Deadline: 20 February 2025)
- New Anti-cancer Agents: Design, Synthesis and Applications (Deadline: 20 February 2025)
- Nose-to-Brain Drug Delivery: Opportunities and Challenges (Deadline: 28 February 2025)
- Drug Development Breakthroughs: From Novel Antimicrobials to Targeted Cancer Drugs (Deadline: 28 February 2025)
- Research and Recent Advances of Antimicrobials (Deadline: 28 February 2025)
- Natural Products and Synthetic Derivatives in Cancer and Inflammatory Diseases (Deadline: 28 February 2025)
- Drug Discovery and Development Focusing on Natural Products (Deadline: 28 February 2025)
- Next-Gen Tissue Engineering in Disease Modelling, Drug Discovery and Immunotherapeutics (Deadline: 28 February 2025)
- Antimicrobial and Antiviral Peptides (Deadline: 20 March 2025)
- Liposomes as Membrane Models in Drug-Lipid Interactions (Deadline: 20 March 2025)
- Epigenetics and Beyond: New Advances in Drug Discovery (Deadline: 20 March 2025)
- Topoisomerase Inhibitors: Future Perspectives and Challenges (Deadline: 20 March 2025)
- Emerging Topics in Metal Complexes: Pharmacological Activity, 2nd Edition (Deadline: 20 March 2025)
- Molecular Computer Science and Artificial Intelligence for Drug Discovery (Deadline: 20 March 2025)
- Redox Regulation and Drug Discovery (Deadline: 20 March 2025)
- Natural Products as Multitarget Agents in Human Diseases (Deadline: 20 March 2025)
- RNA Vaccines and Therapeutics: Challenges and Opportunities (Deadline: 20 March 2025)
- New Advances on Photosensitiser or Inhibitors Molecules for Cancer Treatment (Deadline: 20 March 2025)
- Recent Research on Novel Lipid-Based Nano Drug Delivery Systems (Deadline: 20 March 2025)
- Inhibitors of PARP to Kill Cancer Cells (Deadline: 20 April 2025)
- Pharmacology and Toxicology of Synthetic and Natural Products (Deadline: 30 April 2025)
- Molecular Pharmacological Advances in Gastrointestinal Health (Deadline: 26 May 2025)
- State-of-the-Art Molecular Pharmacology in USA (Deadline: 20 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions: